Mosunetuzumab-Axgb 1 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1 mg/mL
Reference Brands: Lunsumio (USA/EU)
Category: Oncology Cancer Care
Mosunetuzumab-axgb is a bispecific CD20-directed CD3 T-cell engager. It binds CD20 on B-cells and CD3 on T-cells, bringing T-cells into proximity with cancerous B-cells so the immune system can attack and destroy them. It is used to treat adult patients with relapsed or refractory Follicular Lymphoma (a type of non-Hodgkin B-cell lymphoma) after they have had at least two prior systemic therapies.
Mosunetuzumab-Axgb — third party manufacturing & bulk supply
Mosunetuzumab-Axgb 1 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Mosunetuzumab-Axgb is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Mosunetuzumab-Axgb listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Mosunetuzumab-Axgb →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Mosunetuzumab-axgb is used to treat relapsed or refractory follicular lymphoma in adults who have received at least two prior systemic therapies.
Mosunetuzumab-axgb is a bispecific monoclonal antibody designed to bind both CD20 on B-cells and CD3 on T-cells, directing the immune system to destroy malignant B-cells.
The trade name is Lunsumio.
Lunsumio is manufactured by Genentech, a member of the Roche Group.
The generic name is mosunetuzumab-axgb.
The brand name is Lunsumio.
It is manufactured in the United States and Europe by Genentech/Roche.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
